Cite
APA Citation
Murthy, R., Borges, V. F., Conlin, A., Chaves, J., Chamberlain, M., Gray, T., Vo, A., & Hamilton, E. (2018). tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study. Lancet oncology, 19(7), 880–888. http://access.bl.uk/ark:/81055/vdc_100066429082.0x00000d